Author:
Berge G,Øvrebø S,Eilertsen E,Haugen A,Mollerup S
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Asensi M, Medina I, Ortega A, Carretero J, Bano MC, Obrador E, Estrela JM (2002) Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 33: 387–398
2. Berge G, Mollerup S, Øvrebø S, Hewer A, Phillips DH, Eilertsen E, Haugen A (2004a) Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung. Lung Cancer 45: 289–297
3. Berge G, Øvrebø S, Botnen IV, Hewer A, Phillips DH, Haugen A, Mollerup S (2004b) Resveratrol inhibits benzo[a]pyrene–DNA adduct formation in human bronchial epithelial cells. Br J Cancer 91: 333–338
4. Ciolino HP, Yeh GC (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 56: 760–767
5. Gescher AJ, Steward WP (2003) Relationship between mechanisms, bioavailability, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol Biomarkers Prev 12: 953–957
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献